Please login to the form below

ESMO 2012

This page shows the latest ESMO 2012 news and features for those working in and with pharma, biotech and healthcare.

Roche's T-DM1 activity in breast cancer "outstanding"

The new data from the EMILIA study were presented yesterday at the European Society for Medical Oncology (ESMO) annual meeting, and come from a study involving patients with HER2-positive breast ... 2nd October 2012.

Latest news

Ariad’s lung cancer drug impresses at ESMO

Ariad’ s lung cancer drug impresses at ESMO. Early stage trials demonstrate potential in hard-to-treat patients. ... Presenting data at the annual congress of the European Society for Medical Oncology (ESMO 20120) in Vienna, Austria, Ariad said that an
Merck withdraws EU filing for Erbitux in lung cancer

Merck already sells Erbitux as a treatment for metastatic colorectal cancer and squamous cell carcinoma of the head and neck, bringing in 430m in the first six months of 2012, but ... The data will be presented at the European Society for Medical

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest from PMHub

ESMO 2012 Video and Social Media Highlights

ESMO 2012 Video and Social Media Highlights. Brandcast Health's take on the highlights from the ESMO 2012 congress in Vienna, Austria, including social media insights.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior Account Manager – Med Comms – Kent: Salary TBC

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Medical Writer: Great salary and benefits

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Account Manager / Account Director: Great salary and bebefits

Senior Account Manager or AD - Medical Communications: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior Programme Executive: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Scientific Director: Great salary and bebefits

Medical Writer - (London, Brighton or Copenhagen): Competitive

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Editorial Director – Medical Education – Oxford: Negotiable

Editor – Medical Education Agency – Bucks: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Medical Writer: Great salary and bebefits

Subscribe to our email news alerts

PMHub

Add my company

HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

No incentive for a cure: The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...